A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
MacroGenics
MacroGenics
Xencor, Inc.
PharmaMar
Exelixis
Eli Lilly and Company
Xencor, Inc.
Ohio State University Comprehensive Cancer Center
Corcept Therapeutics
MacroGenics
Gilead Sciences
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
City of Hope Medical Center
Swiss Cancer Institute
Pfizer
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Arizona
Case Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
University of California, San Francisco
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Northwestern University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
University of Utah
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
NYU Langone Health
NYU Langone Health